The FDA stops Regenexx stem cell therapy for orthopedics

FDA Hauls Regenexx Into Court This is a watershed case for stem cells applications in orthopedics. The FDA says that Regenexx is not approved and "no adequate and well-controlled studies have been done to demonstrate its safety or effectiveness for any indication."...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top